ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of Moderate Buy from Analysts

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 1-year target […]

Related Keywords

United States ,China ,Jason Lettmann ,Stifel Nicolaus ,Zurcher Kantonalbank Zurich Cantonalbank ,Jaume Pons ,Hsbc Holdings ,Oncology Holdings Inc ,Alx Oncology Holdings Inc ,Securities Exchange Commission ,China Universal Asset Management Co ,Sg Americas Securities ,Oncology Company Profile ,Nasdaq ,Cantor Fitzgerald ,Get Free Report ,Stock Down ,Exchange Commission ,Universal Asset Management ,Kantonalbank Zurich Cantonalbank ,Get Free ,Holdings Inc ,